Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT03576820
Eligibility Criteria:
Inclusion Criteria:
* Patients who will be receiving IV metoclopramide because their migraine is refractory to oral analgesics, as determined by the treating physician.
* Moderate to severe headache with NRS score greater than or equal to 6
* Headache lasting between 2-72 hours
* Two of the following:
1. non-occipital location of headache (frontal, frontotemporal, or unilateral)
2. pulsating or throbbing quality
3. aggravated by or causing avoidance of routine physical activity
4. nausea, vomiting, or both
5. photophobia and/or phonophobia (may be inferred from behavior)
Exclusion Criteria:
* unstable vital signs
* pregnancy
* lactating
* altered mental status
* developmental delay
* intractable vomiting
* first-time headache
* history of cardiac arrythmia
* previous adverse reaction or allergy to lidocaine
* non-English speaking
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
20 Years
Study:
NCT03576820
Study Brief:
Protocol Section:
NCT03576820